Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Standard & Poor’s" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Standard & Poor’s for you to read. Along with our medical data and news we also list Standard & Poor’s Clinical Trials, which are updated daily. BioPortfolio also has a large database of Standard & Poor’s Companies for you to search.
Topcon Healthcare Solutions, Inc., a wholly-owned subsidiary of Topcon America Corporation (“Topcon”) based in Oakland, NJ, has announced that eye health provider Specsavers had recently completed equipping its stores with Topcon's Optical Coherence Tomography (OCT) instruments. On September 21, 2018, Specsavers had reported that Specsavers Blacktown (...
PAA’s S-LAB micro-plate handling capability will be integrated with Sphere Fluidics’ Cyto-Mine Single Cell Analysis System Cambridge and Farnborough, UK, 15 January 2019: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, and Peak Analysis and Automation (PAA), a leader in the industry for the d...
Personalized treatment plans may extend life expectancy for early-stage kidney cancer patients who have risk factors for worsening kidney disease, according to a new study published Tuesday, January 15, in the journal Radiology. OAK BROOK, Ill. (PRWEB) January 15, 2019 Personalized treatment plans may extend life expectancy for early-stage kidney cancer patients who have risk factors for worsenin...
The European Commission has approved nivolumab combined with low-dose ipilimumab as a frontline treatment for patients with intermediate- and poor-risk advanced renal cell carcinoma.
Mark Blecher, M.D. at Philadelphia Eye Associates in Philadelphia, Pa., is participating in the AcuFocus clinical study for the IC-8 intraocular lens (IOL) designed for patients with cataracts. “Participating i
Approval Puts RAPID in a Class of Its Own for Diagnosing and Treating Stroke iSchemaView, the worldwide leader in advanced imaging for stroke, today announced that the FDA has cleared the RAPID neuroimaging platform for use in selecting stroke patients who are likely to benefit from endovascular thrombectomy (clot removal). Specifically, this additiona...
Odds of short-term remission in ulcerative colitis were higher using anaerobically prepared pooled donor stool versus standard autologous stool.
Cloud-based platform leverages micro-services and a highly flexible database to enable improved user experience Accenture (NYSE:ACN) has helped CAQH, a non-profit healthcare alliance, launch a new technol
FDA’s record-breaking year for approvals affirms high value provided by model-informed drug development Certara®, the global leader in model-informed drug development, regulatory science, real-world evidence and market access services, today reported that more than 90% of novel new drug approvals by the US Food and Drug Administration (FDA) in 2018 ...
Closing Out First Year in Distribution, VYBES Expands to 1,400 stores in 17 states, and More Than 1.1 Million Bottles Produced As it rounds out its first year of sales, VYBES, a line of organic, ready-to-drink beverages, has become the largest Hemp CBD beverage by market share in the U.S. – based on first-year sales, national expansion, distribution ...
The European Commission has approved Bristol-Myers Squibb's Opdivo in combination with low-dose Yervoy for first-line treatment of patients with intermediate and poor risk advanced renal cell carcinoma (RCC).
Industry group’s first technology standard to make it easier for sponsors and CROs to share information during clinical trials NEW YORK–(BUSINESS WIRE)–lt;a href=”https://twitter.com/hashtag/CROs?src=hash” target=”_blank”gt;#CROslt;/agt;–Align Clinical CRO, a life sciences industry standards group that includes eight leading contract research organizatio...
TUESDAY, Jan. 15, 2019 -- A stem cell transplant may help some people with multiple sclerosis (MS) when standard drugs fail, a new clinical trial finds. The study focused on 110 patients with aggressive cases of MS: Their symptoms had flared up at...
Ireland-based Presbia has completed its ISO 13485:2016 audit with no major findings, allowing it to proceed with efforts to b -More-
Global health service company Cigna Corporation (NYSE:CI) today kicks off Healthier Kids for Our Future, a $25 million five-year global initiative to improve the health and well-being of children. Cigna's 74,000 global employees will work together to put children on a healthier path, starting with reducing childhood hunger and improving nutrition in local ...
MSD’s Keytruda has cut the risk of death by 31% in patients with esophageal or esophagogastric junction carcinoma or adenocarcinoma who progressed after standard therapy. The results, from the phase 3 KEYNOTE-181 study, pave the way for yet anothe...
In this multicenter, randomized, open-label trial of patients who failed a spontaneous breathing trial, those who were extubated to noninvasive ventilation did not have a shorter time to liberation from any form of mechanical ventilation compared to those who were randomized to protocolized standard weaning.
(MedPage Today) -- New HER2+ standard, CDK4/6 survival bump, skipping chemotherapy
Portable packaging provides barrier integrity similar to standard blister solutions
Arbor Biosciences, a worldwide leader in next generation sequencing (NGS) target enrichment and synthetic biology, announces their partnership with the International Wheat Genome Sequencing Consortium (IWGSC), an international organization dedicated to developing a gold-standard reference genome for bread wheat cv. Chinese Spring. This strategic partnership will provide IWGSC members with a standa...
Measuring total oxidizable carbon (TOC) in water has become a standard quality test for many industries...
To diagnose or exclude tuberculosis can be challenging because of the varied clinical signs and the limitations of diagnostic tests. Tuberculosis diagnosis has evolved from autopsies and histology to radiography and microbiological tests, with culture as the ultimate gold standard. Interferon-γ release assays (IGRAs) measure T-cell responses to Mycobacterium tuberculosis-specific antigens. Althou...
Merck’s KEYTRUDA® (pembrolizumab) Reduced Risk of Death by 31 Percent Compared to Chemotherapy in Previously Treated Patients with Advanced Esophageal or Esophagogastric Junction Carcinoma Whose Tumors Expressed PD-L1 (CPS ≥10)
Results from Phase 3 KEYNOTE-181 Trial to be Presented at 2019 Gastrointestinal Cancers Symposium (ASCO GI) Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the first presentation of results from KEYNOTE-181, a Phase 3 trial investigating KEYTRUDA, Merck’s anti-PD-1 therapy, as monotherapy for the second-line treat...
$BMY EC Approves Opdivo Plus Low-Dose Yervoy for First-Line Treatment of Patients with Intermediate- and Poor-Risk Advanced Renal Cell Carcinoma